Grantham, Mayo, Van Otterloo & Co (GMO)
SBBP

Grantham, Mayo, Van Otterloo & Co (GMO)’s Strongbridge Biopharma plc. SBBP Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-54,300
Closed -$114K – 909
2020
Q3 		$114K Buy
+54,300
New +$183K ﹤0.01% 744

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s SBBP Position: Q4 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2020, closing a stake of 54,300 shares — an estimated $114K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SBBP in Q3 2020 and held it in 1 quarter. The position peaked at $114K in Q3 2020. 71 funds tracked by Wall St. Rank hold SBBP as of Q4 2020.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Strongbridge Biopharma plc. position as of Q4 2020 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 54,300 Strongbridge Biopharma plc. shares in Q4 2020, an estimated $114K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Strongbridge Biopharma plc. in Q3 2020 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Strongbridge Biopharma plc. position peaked at $114K in Q3 2020.
  • 71 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2020, filed 12 Feb 2021.